SELLAS Life Sciences Group, Inc. (SLS)
14.32
-1.14
(-7.34%)
USD |
NASDAQ |
Aug 24, 16:00
14.32
0.00 (0.00%)
After-Hours: 19:58
SELLAS Life Sciences Group Price to Book Value : 21.01 for Aug. 24, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 21, 2026 | 22.68 |
| August 20, 2026 | 19.66 |
| August 19, 2026 | 20.32 |
| August 18, 2026 | 19.22 |
| August 17, 2026 | 19.07 |
| August 14, 2026 | 18.75 |
| August 13, 2026 | 18.13 |
| August 12, 2026 | 17.26 |
| August 11, 2026 | 16.21 |
| August 10, 2026 | 16.19 |
| August 07, 2026 | 17.62 |
| August 06, 2026 | 17.16 |
| August 05, 2026 | 17.40 |
| August 04, 2026 | 17.32 |
| August 03, 2026 | 16.46 |
| July 31, 2026 | 14.68 |
| July 30, 2026 | 15.09 |
| July 29, 2026 | 14.82 |
| July 28, 2026 | 14.80 |
| July 27, 2026 | 15.89 |
| July 24, 2026 | 16.60 |
| July 23, 2026 | 18.10 |
| July 22, 2026 | 17.72 |
| July 21, 2026 | 18.92 |
| July 20, 2026 | 18.30 |
| Date | Value |
|---|---|
| July 17, 2026 | 19.35 |
| July 16, 2026 | 17.24 |
| July 15, 2026 | 18.76 |
| July 14, 2026 | 19.64 |
| July 13, 2026 | 18.51 |
| July 10, 2026 | 18.72 |
| July 09, 2026 | 19.82 |
| July 08, 2026 | 20.18 |
| July 07, 2026 | 19.80 |
| July 06, 2026 | 20.45 |
| July 02, 2026 | 21.97 |
| July 01, 2026 | 19.46 |
| June 30, 2026 | 21.65 |
| June 29, 2026 | 26.08 |
| June 26, 2026 | 20.92 |
| June 25, 2026 | 17.78 |
| June 24, 2026 | 15.48 |
| June 23, 2026 | 15.31 |
| June 22, 2026 | 14.40 |
| June 18, 2026 | 13.59 |
| June 17, 2026 | 13.10 |
| June 16, 2026 | 12.71 |
| June 15, 2026 | 13.05 |
| June 12, 2026 | 13.22 |
| June 11, 2026 | 13.08 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Savara, Inc. | 7.957 |
| Lite Strategy, Inc. | 0.6433 |
| AbbVie, Inc. | -- |
| Marker Therapeutics, Inc. | 2.056 |
| Rezolute, Inc. | 4.121 |
Price to Book Value Related Metrics
| Price | 14.32 |
| Earnings Yield | -1.48% |
| Market Cap | 2.892B |